1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. KOPRAN LTD.

Kopran Ltd.

NSE: KOPRAN | BSE: 524280

Value Stock, Under Radar
Download real time

174.29 4.57 (2.69%)

New 52W Low in past week

99,959 NSE+BSE Volume

NSE 19 Mar, 2025 10:33 AM (IST)

Watchlist

Portfolio

Alert

Share
17S
6W
1O
0T
841.6

Market Cap

Above industry Median
17.7

PE TTM

Below industry Median
1

PEG TTM

PEG TTM is less than 1
1.7

Price to Book

Below industry Median
1.6

Beta 1Year

Very High Volatility


Board Meetings - Kopran Ltd.

The latest board meeting for Kopran Ltd. took place on 11 Feb 2025, for the purpose of Quarterly Results

Share
Ex-date Purpose Notes
11 Feb 2025 Quarterly Results -
13 Nov 2024 Quarterly Results -
08 Aug 2024 Quarterly Results -
16 May 2024 Audited Results & Final Dividend -
07 Feb 2024 Quarterly Results -
07 Nov 2023 Quarterly Results -
10 Aug 2023 Quarterly Results -
25 May 2023 Audited Results & Dividend -
10 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
10 Aug 2022 Quarterly Results -
27 May 2022 Audited Results & Final Dividend -
03 Feb 2022 Quarterly Results -
27 Oct 2021 Quarterly Results -
06 Aug 2021 Quarterly Results -
27 May 2021 Audited Results & Final Dividend -
22 Jan 2021 Quarterly Results -
28 Oct 2020 Quarterly Results & Interim Dividend -
11 Aug 2020 Quarterly Results -
30 Jun 2020 Audited Results -
01 Feb 2020 Quarterly Results -
31 Jan 2020 Quarterly Results -
24 Oct 2019 Quarterly Results -
08 Aug 2019 Quarterly Results -
08 May 2019 Audited Results -
21 Jan 2019 Quarterly Results -
05 Nov 2018 Quarterly Results -
08 Aug 2018 Quarterly Results -
29 May 2018 Audited Results -
13 Feb 2018 Quarterly Results -
14 Dec 2017 Quarterly Results -
13 Sep 2017 Quarterly Results -
24 May 2017 Audited Results -
07 Feb 2017 Quarterly Results -
14 Nov 2016 Quarterly Results 1. Re-appointment of Mr. Surendra Somani, Executive Vice Chairman 2. Mr. Surendra Somani,Executive Vice Chairman, Mr. Ajit Jain, Chief Operating Officer and Mr. Sunil Sodhani, Company Secretary.
09 Aug 2016 Quarterly Results -
30 May 2016 Audited Results -
11 Feb 2016 Quarterly Results -
06 Nov 2015 Quarterly Results -
12 Aug 2015 Quarterly Results -
14 Jul 2015 Others Sale of Consumer Care Division of the Company.
28 May 2015 Audited Results -
13 Feb 2015 Quarterly Results -
12 Nov 2014 Quarterly Results -
29 Sep 2014 Others (1) To consider issue of Equity Shares and/ or Warrants on Preferential basis to Promoter Group. (2) To consider Slump Sales of (API) business to its Subsidiary Co. Kopran Research Laboratories Ltd.
14 Aug 2014 Quarterly Results -
28 May 2014 Audited Results -
13 Feb 2014 Quarterly Results -
13 Nov 2013 Quarterly Results -
10 Aug 2013 Quarterly Results -
29 May 2013 Audited Results -
12 Feb 2013 Quarterly Results -
10 Nov 2012 Quarterly Results -
14 Aug 2012 Quarterly Results -
13 Jul 2012 Audited Results (Revised)
15 May 2012 Quarterly Results -
11 Feb 2012 Quarterly Results -
12 Nov 2011 Quarterly Results -
29 Jul 2011 Audited & Quarterly Results -
14 May 2011 Quarterly Results -
11 Feb 2011 Quarterly Results -
15 Nov 2010 Quarterly Results -
10 Aug 2010 Audited, Quarterly Results & Others The Board has allotted 19,50,000 Equity Shares of Rs. 10/- each for cash at par, (i.e. at a price determined as per SEBI Guidelines) against 19,50,000 CW's held by Panorama Finvest Pvt. Ltd.
14 May 2010 Quarterly Results -
29 Jan 2010 Quarterly Results -
31 Oct 2009 Quarterly Results -
29 Jul 2009 Quarterly Results -
30 Jun 2009 Audited Results & Others To issue on Preferential basis 19,50,000 Warrants and 18,50,000 equity shares of Rs 10 each, to the Promoters / Associates at a price arrived at as per SEBI Guidelines.
30 Jan 2009 Quarterly Results -
25 Oct 2008 Quarterly Results -
11 Oct 2008 Others To divest its stake in the Joint Ventures namely, Globalpharma LLC, Dubai and Kampala Pharmaceutical Industries, Uganda.
30 Jul 2008 Quarterly Results -
30 Jun 2008 Audited Results -
31 Jan 2008 Quarterly Results (Revised)
08 Jan 2008 Audited Results -
03 Jan 2008 Audited Results (18 months) -
21 Sep 2007 Quarterly Results -
30 Jun 2007 Audited Results -
30 Apr 2007 Quarterly Results -
31 Jan 2007 Quarterly Results -
30 Oct 2006 Quarterly Results -
24 Aug 2006 Preferential Allotment of shares To consider Preferential Allotment of Equity Shares pursuant to Section 81(1A) of the Companies Act, 1956 to Banks and Financial Institutions.
31 Jul 2006 Accounts & Quarterly Results -
27 Apr 2006 Quarterly Results -
21 Apr 2006 Allotment of equity shares & Warrants a. 47,20,000 Equity Shares of Rs 10/- each, at a price of Rs 54.70/- per Equity Share b. 58,42,000 Warrants with an option to subscribe into equal number of Equity Shares.
11 Mar 2006 Further issue of Equity Shares Inter alia, to consider, a proposal of further issue of Equity Shares in one or more trenches, by way of private placement / preferential allotment.
31 Jan 2006 Quarterly Results -
24 Oct 2005 Quarterly Results -
03 Jun 2005 Issue and allotment of Warrants Issue and allotment of 12150000 warrants to Clear Water Capital Partner(Cyprus) Ltd.
25 Apr 2005 Unaudited Financial Results -
11 Mar 2005 Issue of equity shares To consider a proposal to further issue of equity in one or more trenches, by way of private placement / preferential allotment of equity shares.
29 Jan 2005 Quarterly Results & Others to finalize the effective date and to consider & approve allotment of Eq. Shares by the Co. to the shareholders of Kopran Pharmaceuticals in view of Order passed by the Hon'ble High Court of Bombay.
29 Oct 2004 Quarterly Results -
31 Jul 2004 Quarterly Results & Accounts -
29 Apr 2004 Quarterly Results -
30 Jan 2004 Quarterly Results -
31 Oct 2003 Quarterly Results -
25 Sep 2003 Accounts -
31 Jul 2003 Quarterly Results (Revised)
29 Apr 2003 Quarterly Results -